Developer docs
API playgroundTry for free, no card

Search company profiles

International Pharmaceutical Company

Full company profile

uuid004nqyc

Namestring
International Pharmaceutical Company
Legal namestring
International Pharmaceuticals Company
Websiteurl
intl-pharma.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

International Pharmaceutical Company is a privately held healthcare distribution company established in 2007 and headquartered in the Al Jurf Industrial Area of Ajman, United Arab Emirates. It operates as a diversified distributor of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements, serving healthcare providers, pharmacies, and medical facilities across the UAE and broader GCC territories. The company's core commercial asset is a portfolio of exclusive distributorship agreements with European and U.S.-based manufacturers — including Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer, and Turkuaz — alongside non-exclusive distribution arrangements with multinationals such as Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma.

The underlying operating capability is a GSDP-compliant storage and distribution infrastructure that supports quality, safety, and efficacy requirements across the supply chain. There is no proprietary technology platform, software product, or digital offering described in the available material; the business model is fundamentally a traditional B2B distribution franchise with sales-led engagement of institutional healthcare buyers.

Revenue mechanics are based on transactional resale of distributed products under exclusive and non-exclusive rights. Pricing is not publicly disclosed and the company operates as a private entity with no disclosed ownership, funding history, leadership team, or financial statements. The firm employs approximately 90 staff based at its Ajman headquarters. The primary data gaps are revenue, profitability, customer concentration by principal or channel, and any plans for digital or technology-led expansion.

Short descriptiontext

International Pharmaceutical Company is a UAE-based healthcare distributor established in 2007, holding exclusive and non-exclusive distribution agreements with European and U.S. manufacturers to supply pharmaceuticals, medical devices, and related healthcare products to providers across the UAE and GCC.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAjman, United Arab Emirates
HQ citystring
Ajman
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, healthcare product distribution, medical device supply, laboratory reagent supply, dietary supplement distribution
Industry2 codes
1Specialty Pharmaceutical Distributors
CodeHLAIAJABPrimaryYes
2Hospital & Health-System Pharmaceutical Distributors
CodeHLAIAJADPrimaryNo
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Distribution
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Distribution
TypeTransaction Fee
Description

International Pharmaceutical Company generates revenue through the distribution of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. They acquire exclusive and non-exclusive distribution rights from pharmaceutical manufacturers and resell to healthcare providers in the UAE and GCC markets.

intl-pharma.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

International Pharmaceuticals Co. distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements across the UAE and GCC. The company serves as the exclusive regional distributor for several international healthcare brands, sourcing products from manufacturers and supplying them to local healthcare providers and pharmacies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

International Pharmaceutical Company operates as a diversified healthcare distribution provider offering a comprehensive portfolio of pharmaceutical and healthcare products. The company distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. The distribution model includes exclusive distributorship agreements with European and U.S.-based companies (Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer and Turkuaz) and serves as a distributor for multinational companies including Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma across the UAE and GCC territories. The product portfolio emphasizes innovative and high-quality solutions delivered through Good Storage and Distribution Practices (GSDP).

Product and service5 records
1Pharmaceutical Distribution
CategoryPharmaceuticals
Description

Distribution of pharmaceutical products sourced from international manufacturers including Qualiphar, Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma, supplied to pharmacies, hospitals, and healthcare providers across the UAE and GCC.

2Medical Device Distribution
CategoryMedical Devices
Description

Distribution of medical devices, including home monitoring devices, sourced from manufacturers such as Anika Therapeutics Inc., supplied to healthcare facilities in the UAE and GCC.

3Laboratory Reagent Distribution
CategoryLaboratory Supplies
Description

Distribution of laboratory reagents for clinical and research laboratories, supplied to medical laboratories and diagnostic facilities across the UAE and GCC.

4Skin and Beauty Care Products Distribution
CategoryPersonal Care
Description

Distribution of skin and beauty care products sourced from brands including Gifrer (France) and ORZAX (Turkey), supplied to pharmacies and consumer health channels in the UAE and GCC.

5Dietary Supplement Distribution
CategoryNutritional Supplements
Description

Distribution of dietary supplements sourced from international brands including Turkuaz (Turkey), supplied to pharmacies and consumer health retailers in the UAE and GCC.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

European-based pharmaceutical/ healthcare company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

U.S.-based medical/ pharmaceutical company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

European-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

European-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

European-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Renowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Multinational medical products company for whom International Pharmaceutical Company serves as distributor in the UAE market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Renowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Renowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UAE-based pharmaceutical distributor operating in the same UAE/GCC region. Comparable direct peer distributing pharmaceutical and healthcare products to regional providers.

TypeDirect peer
Description

UAE-based pharmaceutical manufacturer with regional distribution across MENA markets. Directly comparable as a UAE-rooted pharma company distributing branded and generic products to healthcare providers in the same GCC footprint.

TypeDirect peer
Description

UAE-headquartered pharmaceutical manufacturer and distributor operating across the GCC and MENA. Comparable to International Pharmaceutical Company as a regional pharma distributor serving similar healthcare-provider and pharmacy customers in the same core UAE/GCC geography.

TypeRegional player
Description

Saudi Arabia-based pharmaceutical manufacturer and distributor with strong MENA presence. Comparable regional pharma distributor serving GCC healthcare providers, primarily anchored in Saudi Arabia rather than UAE.

TypeRegional player
Description

Saudi-based pharmaceutical and healthcare distributor serving MENA. Comparable as a regional pharma distribution peer operating primarily from Saudi Arabia into the broader GCC market.

TypeDirect peer
Description

Jordan-headquartered multinational with one of the largest commercial footprints across MENA. Comparable as a regional pharma manufacturer-distributor serving GCC healthcare providers, though at significantly larger scale.

TypeRegional player
Description

Saudi-based pharmaceutical manufacturer and distributor operating across MENA. Comparable regional peer distributing branded and specialty pharma to healthcare providers, primarily from a Saudi rather than UAE base.

TypeDirect peer
Description

UAE-based medical devices and pharmaceutical distributor serving hospitals and clinics across the GCC. Comparable as a UAE-anchored specialty healthcare distributor with a similar product breadth across devices and pharmaceuticals.

TypeBroad incumbent
Description

Multinational pharma and consumer health major with regional headquarters serving the Middle East. Comparable as a broad incumbent that distributes pharmaceuticals and consumer health products across the same GCC region through its own regional operations.

TypeRegional player
Description

Saudi Arabia-based healthcare distribution and manufacturing group with broad pharma and consumer health portfolio. Comparable as a regional GCC healthcare distributor, primarily Saudi-anchored.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Pharmaceutical Company

Pharmaceutical Distributionintl-pharma.com

International Pharmaceutical Company is a UAE-based healthcare distributor established in 2007, holding exclusive and non-exclusive distribution agreements with European and U.S. manufacturers to supply pharmaceuticals, medical devices, and related healthcare products to providers across the UAE and GCC.

What International Pharmaceutical Company does

International Pharmaceutical Company is a privately held healthcare distribution company established in 2007 and headquartered in the Al Jurf Industrial Area of Ajman, United Arab Emirates. It operates as a diversified distributor of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements, serving healthcare providers, pharmacies, and medical facilities across the UAE and broader GCC territories. The company's core commercial asset is a portfolio of exclusive distributorship agreements with European and U.S.-based manufacturers — including Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer, and Turkuaz — alongside non-exclusive distribution arrangements with multinationals such as Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma.

The underlying operating capability is a GSDP-compliant storage and distribution infrastructure that supports quality, safety, and efficacy requirements across the supply chain. There is no proprietary technology platform, software product, or digital offering described in the available material; the business model is fundamentally a traditional B2B distribution franchise with sales-led engagement of institutional healthcare buyers.

Revenue mechanics are based on transactional resale of distributed products under exclusive and non-exclusive rights. Pricing is not publicly disclosed and the company operates as a private entity with no disclosed ownership, funding history, leadership team, or financial statements. The firm employs approximately 90 staff based at its Ajman headquarters. The primary data gaps are revenue, profitability, customer concentration by principal or channel, and any plans for digital or technology-led expansion.

International Pharmaceutical Company firmographics

Firmographics
Name
International Pharmaceutical Company
Legal name
International Pharmaceuticals Company
Website
https://intl-pharma.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
51–100 employees
Short description
International Pharmaceutical Company is a UAE-based healthcare distributor established in 2007, holding exclusive and non-exclusive distribution agreements with European and U.S. manufacturers to supply pharmaceuticals, medical devices, and related healthcare products to providers across the UAE and GCC.
Ownership category
akta.pro rank

International Pharmaceutical Company industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Specialty Pharmaceutical Distributors (HLAIAJAB)
akta.pro secondary industry
Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

  • Pharmaceutical distribution
  • Healthcare product distribution
  • Medical device supply
  • Laboratory reagent supply
  • Dietary supplement distribution

Where International Pharmaceutical Company is headquartered

Location

Headquarters

HQ city
Ajman
HQ country
United Arab Emirates
HQ region
Middle East

Offices1 record

Markets served

International Pharmaceutical Company business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Distribution: International Pharmaceutical Company generates revenue through the distribution of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. They acquire exclusive and non-exclusive distribution rights from pharmaceutical manufacturers and resell to healthcare providers in the UAE and GCC markets.

Go-to-market motion1 record

Distribution channels1 record

International Pharmaceutical Company product offering

Product offering

Core offering

International Pharmaceuticals Co. distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements across the UAE and GCC. The company serves as the exclusive regional distributor for several international healthcare brands, sourcing products from manufacturers and supplying them to local healthcare providers and pharmacies.

Product overview

International Pharmaceutical Company operates as a diversified healthcare distribution provider offering a comprehensive portfolio of pharmaceutical and healthcare products. The company distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. The distribution model includes exclusive distributorship agreements with European and U.S.-based companies (Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer and Turkuaz) and serves as a distributor for multinational companies including Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma across the UAE and GCC territories. The product portfolio emphasizes innovative and high-quality solutions delivered through Good Storage and Distribution Practices (GSDP).

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Distribution Distribution of pharmaceutical products sourced from international manufacturers including Qualiphar, Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma, supplied to pharmacies, hospitals, and healthcare providers across the UAE and GCC.
  • Medical Device Distribution Distribution of medical devices, including home monitoring devices, sourced from manufacturers such as Anika Therapeutics Inc., supplied to healthcare facilities in the UAE and GCC.
  • Laboratory Reagent Distribution Distribution of laboratory reagents for clinical and research laboratories, supplied to medical laboratories and diagnostic facilities across the UAE and GCC.
  • Skin and Beauty Care Products Distribution Distribution of skin and beauty care products sourced from brands including Gifrer (France) and ORZAX (Turkey), supplied to pharmacies and consumer health channels in the UAE and GCC.
  • Dietary Supplement Distribution Distribution of dietary supplements sourced from international brands including Turkuaz (Turkey), supplied to pharmacies and consumer health retailers in the UAE and GCC.

Companies that use International Pharmaceutical Company

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles1 record

International Pharmaceutical Company technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

International Pharmaceutical Company partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core.

  • QualipharcoreChannel Partner/ Reseller/ DistributorEuropean-based pharmaceutical/ healthcare company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
  • Anika Therapeutics InccoreChannel Partner/ Reseller/ DistributorU.S.-based medical/ pharmaceutical company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
  • ORZAXcoreChannel Partner/ Reseller/ DistributorEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
  • GifrercoreChannel Partner/ Reseller/ DistributorEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
  • TurkuazcoreChannel Partner/ Reseller/ DistributorEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
  • Sanofi AventiscoreChannel Partner/ Reseller/ DistributorRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.
  • Merck SonorocoreChannel Partner/ Reseller/ DistributorMultinational medical products company for whom International Pharmaceutical Company serves as distributor in the UAE market.
  • Meda PharmacoreChannel Partner/ Reseller/ DistributorRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.
  • Novartis PharmacoreChannel Partner/ Reseller/ DistributorRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

International Pharmaceutical Company competitors and assessment

Company assessment

Direct peers

  • Global Pharma Healthcare: UAE-based pharmaceutical distributor operating in the same UAE/GCC region. Comparable direct peer distributing pharmaceutical and healthcare products to regional providers.
  • Neopharma: UAE-based pharmaceutical manufacturer with regional distribution across MENA markets. Directly comparable as a UAE-rooted pharma company distributing branded and generic products to healthcare providers in the same GCC footprint.
  • Julphar (Gulf Pharmaceutical Industries): UAE-headquartered pharmaceutical manufacturer and distributor operating across the GCC and MENA. Comparable to International Pharmaceutical Company as a regional pharma distributor serving similar healthcare-provider and pharmacy customers in the same core UAE/GCC geography.
  • Hikma Pharmaceuticals: Jordan-headquartered multinational with one of the largest commercial footprints across MENA. Comparable as a regional pharma manufacturer-distributor serving GCC healthcare providers, though at significantly larger scale.
  • Zahrawi Medical: UAE-based medical devices and pharmaceutical distributor serving hospitals and clinics across the GCC. Comparable as a UAE-anchored specialty healthcare distributor with a similar product breadth across devices and pharmaceuticals.

Regional players

  • Tabuk Pharmaceuticals: Saudi Arabia-based pharmaceutical manufacturer and distributor with strong MENA presence. Comparable regional pharma distributor serving GCC healthcare providers, primarily anchored in Saudi Arabia rather than UAE.
  • Cigalah Group: Saudi-based pharmaceutical and healthcare distributor serving MENA. Comparable as a regional pharma distribution peer operating primarily from Saudi Arabia into the broader GCC market.
  • SPIMACO: Saudi-based pharmaceutical manufacturer and distributor operating across MENA. Comparable regional peer distributing branded and specialty pharma to healthcare providers, primarily from a Saudi rather than UAE base.
  • Tamer Group: Saudi Arabia-based healthcare distribution and manufacturing group with broad pharma and consumer health portfolio. Comparable as a regional GCC healthcare distributor, primarily Saudi-anchored.

Broad incumbents

  • Bayer Middle East: Multinational pharma and consumer health major with regional headquarters serving the Middle East. Comparable as a broad incumbent that distributes pharmaceuticals and consumer health products across the same GCC region through its own regional operations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

International Pharmaceutical Company social profiles

Digital presence

International Pharmaceutical Company compliance and trust

Trust signal

Compliance1 record

International Pharmaceutical Company financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Pharmaceutical Company leadership team

Management profile

Number of profiles

International Pharmaceutical Company funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Pharmaceutical Company M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Pharmaceutical Company

What does International Pharmaceutical Company do?

International Pharmaceuticals Co. distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements across the UAE and GCC. The company serves as the exclusive regional distributor for several international healthcare brands, sourcing products from manufacturers and supplying them to local healthcare providers and pharmacies.

Is International Pharmaceutical Company a public or private company?

International Pharmaceutical Company is a private company. It is classified as unknown and is currently operating.

When was International Pharmaceutical Company founded?

International Pharmaceutical Company was founded in 2007. It employs 51 to 100 people.

Where is International Pharmaceutical Company based?

International Pharmaceutical Company is headquartered in Ajman, United Arab Emirates, in the Middle East region.

How does International Pharmaceutical Company make money?

One revenue line is on record: pharmaceutical Distribution.

Who are International Pharmaceutical Company's main competitors?

Direct peers on record are Global Pharma Healthcare, Neopharma, Julphar (Gulf Pharmaceutical Industries), Hikma Pharmaceuticals and Zahrawi Medical. Regional players are Tabuk Pharmaceuticals, Cigalah Group, SPIMACO and Tamer Group. Bayer Middle East is listed as a broad incumbent.

Does International Pharmaceutical Company have an API?

No public API is recorded for International Pharmaceutical Company.

What industry is International Pharmaceutical Company in?

International Pharmaceutical Company's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales